Neuromedin U derivative
AssigneeTakeda Pharmaceutical Company Limited
InventorsTaiji Asami, Hiroshi Inooka, Naoki Nishizawa
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a novel anorectic agent. Another object of the invention is to provide an NMU derivative which exhibits a high anorectic effect even when administered in a usual manner, for example, peripherally. These objects can be achieved by the compound represented by formula (I) or a salt thereof. In formula (I), Y represents a polypeptide containing an amino acid sequence set forth in SEQ ID NO.: 1 wherein 1 to 4 amino acids are substituted; X represents a methoxypolyethylene glycol; X′ is absent or represents a methoxypolyethylene glycol; and a moiety represented by formula: La-Lb-[Lc]j represents a linker.
Claims9
A compound represented by formula
- wherein Y represents a polypeptide consisting of an amino acid sequence set forth in SEQ ID NO.:
- 1 wherein 1 to 4 amino acids are substituted,
- the amino acid substitution is selected from:
- (1) substitution of Tyr at position 1 with Arg, NMeArg, or Pro;
- (2) substitution of Phe at position 2 with Nal(2);
- (3) substitution of Leu at position 3 with Gln, Arg, Val, Cha or NMeArg;
- (4) substitution of Arg at position 5 with Gln or NMeArg;
- (5) substitution of Pro at position 6 with NMeAla;
- and
- (6) substitution of Arg at position 7 with Arg(Me);
- X represents a methoxypolyethylene glycol;
- X′ is absent or represents a methoxypolyethylene glycol;
- La is a divalent or trivalent group represented by formula
- wherein R represents a bond and n is an integer of 0;
- Lb represents —(CH2)i— wherein I is an integer of 1 to 5;
- Lc is a divalent group represented by formula (i):
- —NH-Qc-Cb—
- wherein Qc is a divalent group represented by formula:
- —(CH2)m1—
- wherein m1 is an integer of 0 to 15, and Cb represents a bond, —CO— or —SO2—, or
- a divalent group represented by formula (ii):
- -Qc′-Cb′—
- wherein Qc represents a divalent group selected from formula:
- —(CH2)m1′—Zc′—(CH2)m2′—
- wherein m1′ is an integer of 0 to 15,
- Zc′ represents
- and m2′ is an integer of 0 to 15, and
- Cb represents a bond, —CO— or —SO2—;
- and
- j is an integer of 1 to 3;
- or
- a salt thereof,
- wherein the amino acid substitution includes (1) substitution of Phe at position 2 with Nal(2);
- (2) substitution of Pro at position 6 with NMeAla;
- or both.
A compound wherein the amino acid sequence consists of SEQ ID No. 20:
- PEG20k-NpipAc-Tyr-Nal(2)-Leu-Phe-Arg-NMeAla-Arg-Asn-NH2 or a salt thereof.
Dependencies are inferred from the claim text.